BlackRock’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-596
Closed -$5K 3369
2015
Q1
$5K Hold
596
﹤0.01% 3062
2014
Q4
$6K Hold
596
﹤0.01% 3048
2014
Q3
$5K Hold
596
﹤0.01% 3115
2014
Q2
$7K Hold
596
﹤0.01% 3054
2014
Q1
$8K Buy
596
+161
+37% +$2.08K ﹤0.01% 2911
2013
Q4
$5K Hold
435
﹤0.01% 3083
2013
Q3
$5K Hold
435
﹤0.01% 3030
2013
Q2
$6K Buy
+435
New +$5.59K ﹤0.01% 3017

Other funds holding DSCI

BlackRock's DSCI Position: Q2 2015 in Review

BlackRock sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q2 2015, closing a stake of 596 shares — an estimated $5K sold.

BlackRock first reported a position in DSCI in Q2 2013 and held it in 8 quarters. The position peaked at $8K in Q1 2014. 62 funds tracked by Wall St. Rank hold DSCI as of Q2 2015.

  • BlackRock reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q2 2015 after selling out during the quarter.
  • BlackRock sold 596 Derma Sciences, Inc. Common Stock (DE) shares in Q2 2015, an estimated $5K.
  • BlackRock first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and held it in 8 quarters.
  • BlackRock's Derma Sciences, Inc. Common Stock (DE) position peaked at $8K in Q1 2014.
  • 62 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q2 2015.

Based on BlackRock's 13F filing for Q2 2015, filed 7 Aug 2015.